METTL3 and Sepsis: The team conducted in vivo experiments using METTL3-knockdown murine models versus wild-type counterparts, and demonstrated that METTL3 deficiency exacerbated endothelial barrier disruption, amplified sepsis-induced inflammatory responses, and consequently aggravated pulmonary injury.